Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension
- 1 January 2007
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 49 (1), 232-236
- https://doi.org/10.1161/01.hyp.0000252210.58849.78
Abstract
Tryptophan hydroxylase 1 catalyzes the rate-limiting step in the synthesis of serotonin in the periphery. Recently, it has been shown that expression of the tryptophan hydroxylase 1 gene is increased in lungs and pulmonary endothelial cells from patients with idiopathic pulmonary arterial hypertension. Here we investigated the effect of genetic deletion of tryptophan hydroxylase 1 on hypoxia-induced pulmonary arterial hypertension in mice by measuring pulmonary hemodynamics and pulmonary vascular remodeling before and after 2 weeks of hypoxia. In wild-type mice, hypoxia increased right ventricular pressure and pulmonary vascular remodeling. These effects of hypoxia were attenuated in the tryptophan hydroxylase 1-/-mice. Hypoxia increased right ventricular hypertrophy in both wild-type and tryptophan hydroxylase 1-/-mice suggesting that in vivo peripheral serotonin has a differential effect on the pulmonary vasculature and right ventricular hypertrophy. Contractile responses to serotonin were increased in pulmonary arteries from tryptophan hydroxylase 1-/-mice. Hypoxia increased serotonin-mediated contraction in vessels from the wild-type mice, but this was not further increased by hypoxia in the tryptophan hydroxylase 1-/-mice. In conclusion, these results indicate that tryptophan hydroxylase 1 and peripheral serotonin play an essential role in the development of hypoxia-induced elevations in pulmonary pressures and hypoxia-induced pulmonary vascular remodeling. In addition, the results suggest that, in mice, serotonin has differential effects on the pulmonary vasculature and right ventricular hypertrophy.Keywords
This publication has 24 references indexed in Scilit:
- Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary HypertensionCirculation, 2006
- Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2 -Deficient MiceCirculation Research, 2006
- Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2BReceptors in MiceJournal of Pharmacology and Experimental Therapeutics, 2006
- Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung developmentAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- (+)-Norfenfluramine-Induced Arterial Contraction Is Not Dependent on Endogenous 5-Hydroxytryptamine or 5-Hydroxytryptamine TransporterJournal of Pharmacology and Experimental Therapeutics, 2005
- Overexpression of the 5-Hydroxytryptamine Transporter GeneCirculation, 2004
- Synthesis of Serotonin by a Second Tryptophan Hydroxylase IsoformScience, 2003
- Increased contractile response to 5‐hydroxytryptamine1‐receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergyBritish Journal of Pharmacology, 2001
- Pulmonary Hypertension Induced in Rats by Monocrotaline and Chronic Hypoxia is Reduced by p-ChlorophenylalanineRespiration, 1985
- Chemical sympathectomy and serotonin inhibition reduce monocrotaline-induced right ventricular hypertrophy in ratsCanadian Journal of Physiology and Pharmacology, 1983